Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia

Seminars in Oncology

Volumn 39, Issue 6, 2012, Pages 707-715

  Vago, Luca ^a   Toffalori, Cristina ^a   Ciceri, Fabio ^a   Fleischhauer, Katharina ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANTIGEN PRESENTATION; CHIMERA; GRAFT VERSUS LEUKEMIA EFFECT; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HLA TYPING; HUMAN; LEUKEMIA RELAPSE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TUMOR ESCAPE; UNIPARENTAL DISOMY;

EID: 84870661923     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.09.009     Document Type: Article

References (51)

1. F. Aversa, A. Tabilio, A. Velardi Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype N Engl J Med 339 1998 1186 1193
2. L. Ruggeri, M. Capanni, E. Urbani Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
3. L. Ruggeri, A. Mancusi, M. Capanni Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value Blood 110 2007 433 440
4. L. Ruggeri, F. Aversa, M.F. Martelli, A. Velardi Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self Immunol Rev 214 2006 202 218
5. F. Aversa, A. Terenzi, A. Tabilio Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 2005 3447 3454
6. F. Ciceri, M. Labopin, F. Aversa A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation Blood 112 2008 3574 3581
7. M. Di Ianni, F. Falzetti, A. Carotti Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation Blood 117 2011 3921 3928
8. F. Ciceri, C. Bonini, M.T. Stanghellini Infusion of suicide-gene- engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study Lancet Oncol 10 2009 489 500
9. A. Di Stasi, S.K. Tey, G. Dotti Inducible apoptosis as a safety switch for adoptive cell therapy N Engl J Med 365 2011 1673 1683
10. L. Luznik, R.J. Jones, E.J. Fuchs High-dose cyclophosphamide for graft-versus-host disease prevention Curr Opin Hematol 17 2010 493 499
11. K.A. Hogquist, T.A. Baldwin, S.C. Jameson Central tolerance: learning self-control in the thymus Nat Rev Immunol 5 2005 772 782
12. E.J. Suchin, P.B. Langmuir, E. Palmer, M.H. Sayegh, A.D. Wells, L.A. Turka Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question J Immunol 166 2001 973 981
13. C. Smith, J.J. Miles, R. Khanna Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure Am J Transplant 12 2012 15 26
14. C.T. Spencer, P. Gilchuk, S.M. Dragovic, S. Joyce Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand Curr Opin Organ Transplant 15 2010 512 525
15. E.A. Copelan Hematopoietic stem-cell transplantation N Engl J Med 354 2006 1813 1826
16. O. Ringden, M. Labopin, N.C. Gorin Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia? Br J Haematol 111 2000 1130 1137
17. M.M. Horowitz, R.P. Gale, P.M. Sondel Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555 562
18. B.E. Shaw, T.A. Gooley, M. Malkki The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation Blood 110 2007 4560 4566
19. K. Fleischhauer, B.E. Shaw, T. Gooley Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study Lancet Oncol 13 2012 366 374
20. F. Garrido, I. Algarra MHC antigens and tumor escape from immune surveillance Adv Cancer Res 83 2001 117 158
21. H.T. Khong, N.P. Restifo Natural selection of tumor variants in the generation of "tumor escape" phenotypes Nat Immunol 3 2002 999 1005
22. M. Ahmad, R.C. Rees, S.A. Ali Escape from immunotherapy: possible mechanisms that influence tumor regression/progression Cancer Immunol Immunother 53 2004 844 854
23. B. Seliger, M.J. Maeurer, S. Ferrone Antigen-processing machinery breakdown and tumor growth Immunol Today 21 2000 455 464
24. P. Jimenez, J. Canton, A. Collado Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors Int J Cancer 83 1999 91 97
25. B. Seliger Molecular mechanisms of MHC class I abnormalities and APM components in human tumors Cancer Immunol Immunother 57 2008 1719 1726
26. N.P. Restifo, F.M. Marincola, Y. Kawakami, J. Taubenberger, J.R. Yannelli, S.A. Rosenberg Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy J Natl Cancer Inst 88 1996 100 108
27. R. Carretero, J.M. Romero, F. Ruiz-Cabello Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy Immunogenetics 60 2008 439 447
28. R.E. Brouwer, P. van der Heiden, G.M. Schreuder Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon Hum Immunol 63 2002 200 210
29. K. Masuda, A. Hiraki, N. Fujii Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts Cancer Sci 98 2007 102 108
30. P. Bader, H. Kreyenberg, W. Hoelle Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 22 2004 1696 1705
31. B. Mazzi, T.D. Clerici, M. Zanussi Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors Leukemia 22 2008 2119 2122
32. L. Vago, S.K. Perna, M. Zanussi Loss of mismatched HLA in leukemia after stem-cell transplantation N Engl J Med 361 2009 478 488
33. C. O'Keefe, M.A. McDevitt, J.P. Maciejewski Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies Blood 115 2010 2731 2739
34. I.B. Villalobos, Y. Takahashi, Y. Akatsuka Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation Blood 115 2010 3158 3161
35. H.J. Kolb Graft-versus-leukemia effects of transplantation and donor lymphocytes Blood 112 2008 4371 4383
36. V. Dubois, F. Sloan-Bena, A. Cesbron Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy Leukemia 26 2012 2079 2085
37. A.G. Smith, W. Fan, L. Regen Somatic mutations in the HLA genes of patients with hematological malignancy Tissue Antigens 79 2012 359 366
38. M. Gupta, M. Raghavan, R.E. Gale Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia Genes Chromosomes Cancer 47 2008 729 739
39. L. Bullinger, J. Kronke, C. Schon Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis Leukemia 2009
40. M. Raghavan, L.L. Smith, D.M. Lillington Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia Blood 112 2008 814 821
41. E.W. Petersdorf Optimal HLA matching in hematopoietic cell transplantation CurrI Opin Immunol 20 2008 588 593
42. E. Gluckman Milestones in umbilical cord blood transplantation Blood Rev 25 2011 255 259
43. J.R. Passweg, H. Baldomero, A. Gratwohl The EBMT activity survey: 1990-2010 Bone Marrow Transplant 47 2012 906 923
44. M. Waterhouse, D. Pfeifer, M. Pantic, F. Emmerich, H. Bertz, J. Finke Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 17 2011 1450 1459
45. C. Toffalori, I. Cavattoni, S. Deola Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT Blood 119 2012
46. F. Stolzel, K. Hackmann, F. Kuithan Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation Transplantation 93 2012 744 749
47. T. Isoda, A.M. Ford, D. Tomizawa Immunologically silent cancer clone transmission from mother to offspring Proc Natl Acad Sci U S A 106 2009 17882 17885
48. T. Katagiri, A. Matsubara, K. Kashiwase Immunologically-selected hematopoiesis caused by HLA allelic loss in patients with aplastic anemia Blood 116 2010 198
49. N. Kroger, U. Bacher, P. Bader NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes Biol Blood Marrow Transplant 16 2010 1187 1211
50. J. Barrett, B.R. Blazar Genetic trickery - escape of leukemia from immune attack N Engl J Med 361 2009 524 525
51. S. Nguyen, V. Beziat, F. Norol Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation Transfusion 51 2011 1769 1778